These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

49 related items for PubMed ID: 8361478

  • 1. [Stimulation of tissue lipoprotein lipase activity in cancer cachectic rats: preliminary report].
    Nomura K, Noguchi Y, Yoshikawa T, Fukuzawa K, Tuburaya A, Yoshida S, Matsumoto A.
    Nihon Geka Gakkai Zasshi; 1993 Jul; 94(7):759. PubMed ID: 8361478
    [No Abstract] [Full Text] [Related]

  • 2. Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
    Nomura K, Noguchi Y, Matsumoto A.
    Surg Today; 1996 Jul; 26(2):89-94. PubMed ID: 8919277
    [Abstract] [Full Text] [Related]

  • 3. Effect of lipoprotein lipase activators bezafibrate and NO-1886, on B16 melanoma-induced cachexia in mice.
    Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Goto T.
    Anticancer Res; 1999 Jul; 19(5B):4099-103. PubMed ID: 10628360
    [Abstract] [Full Text] [Related]

  • 4. [Insulin resistance and fat metabolism in the tumor-bearing state: preliminary report].
    Noguchi Y, Yoshikawa T, Nomura K, Tsuburaya A, Fukuzawa K, Makino T, Matsumoto A.
    Nihon Geka Gakkai Zasshi; 1994 Feb; 95(2):131. PubMed ID: 8121386
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
    Sheppard BC, Venzon D, Fraker DL, Langstein HN, Jensen JC, Norton JA.
    Cancer Res; 1990 Jul 01; 50(13):3928-33. PubMed ID: 2354441
    [Abstract] [Full Text] [Related]

  • 8. Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.
    Tsujimoto S, Kawamura I, Inami M, Lacey E, Nishigaki F, Naoe Y, Manda T, Goto T.
    Anticancer Res; 2000 Jul 01; 20(5A):3111-6. PubMed ID: 11062730
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Experimental cachexia: effects of MCA sarcoma in the Fischer rat.
    Smith BK, Conn CA, Kluger MJ.
    Am J Physiol; 1993 Aug 01; 265(2 Pt 2):R376-84. PubMed ID: 8368392
    [Abstract] [Full Text] [Related]

  • 11. Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.
    Noguchi Y, Vydelingum NA, Younes RN, Fried SK, Brennan MF.
    Cancer Res; 1991 Feb 01; 51(3):863-9. PubMed ID: 1988126
    [Abstract] [Full Text] [Related]

  • 12. Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.
    Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Naoe Y, Inami M, Manda T, Shimomura K.
    Anticancer Res; 1999 Feb 01; 19(1A):341-8. PubMed ID: 10226565
    [Abstract] [Full Text] [Related]

  • 13. Early detection of cancer cachexia in the rat using 31P magnetic resonance spectroscopy of the liver and a fructose stress test.
    Gehman KE, Inculet RI, Brauer M, Marsh GD, Driedger AA, Thompson RT.
    NMR Biomed; 1996 Sep 01; 9(6):271-5. PubMed ID: 9073305
    [Abstract] [Full Text] [Related]

  • 14. The possible role of TNF-alpha and IL-2 in inducing tumor-associated metabolic alterations.
    Noguchi Y, Makino T, Yoshikawa T, Nomura K, Fukuzawa K, Matsumoto A, Yamada T.
    Surg Today; 1996 Sep 01; 26(1):36-41. PubMed ID: 8680118
    [Abstract] [Full Text] [Related]

  • 15. Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
    Kobayashi J, Takahashi K, Tashiro J, Shirai K, Saito Y, Yoshida S, Hashimoto H, Fukamachi I, Niihara K, Sasaki N.
    Arzneimittelforschung; 1994 Feb 01; 44(2):145-8. PubMed ID: 8147947
    [Abstract] [Full Text] [Related]

  • 16. Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients.
    Nomura K, Noguchi Y, Yoshikawa T, Kondo J.
    Hepatogastroenterology; 1997 Feb 01; 44(17):1519-26. PubMed ID: 9356883
    [Abstract] [Full Text] [Related]

  • 17. Development of altered taste preferences in tumor-bearing rats.
    Smith BK, Barker K, Schork MA, Kluger MJ.
    Appetite; 1994 Dec 01; 23(3):219-30. PubMed ID: 7726541
    [Abstract] [Full Text] [Related]

  • 18. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
    Grunfeld C, Wilking H, Neese R, Gavin LA, Moser AH, Gulli R, Serio MK, Feingold KR.
    Cancer Res; 1989 May 15; 49(10):2554-60. PubMed ID: 2713842
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein lipase activity in adipose tissue of spontaneously hyperlipidemic rats.
    Gustafsson K, Kiessling H, Boberg J.
    Artery; 1981 May 15; 9(5):394-404. PubMed ID: 7198433
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of IRS-1 phosphorylation and the alterations of GLUT4 in isolated adipocytes from cachectic tumor-bearing rats.
    Yoshikawa T, Noguchi Y, Satoh S.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):676-81. PubMed ID: 10080958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.